Press Releases Acura Pharmaceuticals, Inc.

Equities

ACUR

US00509L8028

Market Closed - OTC Markets Other stock markets 03:39:25 2024-05-03 pm EDT			5-day change	1st Jan Change
0.0041 ^USD	+36.67%		-59.00%	+4,000.00%

Mar. 26	Acura Pharmaceuticals, Inc. Announces Amendment to the Agreement with Abuse Deterrent Pharma, LLC	CI
Mar. 14	Acura Pharmaceuticals, Inc. announced that it has received $0.25 million in funding from Abuse Deterrent Pharma, LLC	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Acura Pharmaceuticals : TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT - Form 8-K	Mar. 26	PU
Acura Pharmaceuticals : AMENDED, CONSOLIDATED AND RESTATED SECURED PROMISSORY NOTE - Form 8-K	Dec. 21	PU
Acura Pharmaceuticals : New Financial Obligation - Form 8-K	Dec. 06	PU
Acura Pharmaceuticals : Termination of Material Agreement - Form 8-K	23-08-16	PU
Acura Pharmaceuticals : TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT - Form 8-K	23-06-28	PU
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	23-03-20	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	23-02-22	AQ
ACURA PHARMACEUTICALS, INC : Other Events (form 8-K)	23-02-13	AQ
ACURA PHARMACEUTICALS, INC : Other Events (form 8-K)	23-02-02	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	23-01-20	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-12-27	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	22-11-14	AQ
Acura Pharmaceuticals : NEGOTIABLE PROMISSORY NOTE - Form 8-K	22-10-17	PU
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-10-17	AQ
Acura Pharmaceuticals : NEGOTIABLE PROMISSORY NOTE - Form 8-K	22-09-26	PU
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-09-26	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-08-26	AQ
ACURA PHARMACEUTICALS, INC : Other Events (form 8-K)	22-07-28	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-07-19	AQ
ACURA PHARMACEUTICALS, INC : Other Events (form 8-K)	22-07-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Acura Pharmaceuticals, Inc.

Equities

ACUR

US00509L8028

Press Releases

Filters